Author

A. Munder

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Biochemistry· 1 Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 2 Approach:experimental assay· 1 Organism:human· 1 Approach:statistical model· 1 Assay:whole-genome sequencing· 1

Frequent Co-Authors

A. Batra· 1 shared A. Gruzman· 1 shared A. Meir· 1 shared B. Tuemmler· 1 shared F. Buchholz· 1 shared F. Schwerdtfeger· 1 shared H. Schulenburg· 1 shared J. Botelho· 1 shared

Activity by Year

2019-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 24 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperMicrobiology

A. Batra

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Variation in the response to antibiotics and life-history across the major Pseudomonas aeruginosa clone type (mPact) panel

L. Tueffers, A. Batra, J. Zimmermann, J. Botelho, F. Buchholz, J. Liao, N. Mendoza Mejia, A. Munder, J. Klockgether, B. Tuemmler, J. Rupp, H. Schulenburg

The paper evaluates antibiotic resistance and life-history traits across 20 Pseudomonas aeruginosa strains to identify adaptive strategies and inform new treatment approaches.

bioRxiv · Jan 15, 2024 · PreprintMicrobiology

Inhibiting the copper efflux system in microbes as a novel approach for developing antibiotics

A. Meir, V. Lepechkin-Zilbermintz, S. Kahremany, F. Schwerdtfeger, L. Gevorkyan-Airapetov, A. Munder, O. Viskind, A. Gruzman, S. Ruthstein

This study develops peptide inhibitors targeting the bacterial copper efflux system CusCFBA to combat antibiotic resistance by exploiting copper toxicity.

bioRxiv · Sep 9, 2019Biochemistry